A team at Nashville, Tenn.-based Vanderbilt Heart and Vascular Institute successfully employed a robotic device to place a patient’s central line.
Vanderbilt Health is one of five centers selected by the FDA to study the Obvius Robotics device for central line placement, according to a March 18 news release.
Led by Aniket Rali, MD, co-director of the medical cardiovascular ICU, the team first used the device in January on a patient receiving a pulmonary artery pressure monitoring device.
“It basically does the job of what may take a human experience over 100 cases to perform with that level of precision and safety,” Dr. Rali said in the news release. “It makes the entire process of getting the needle into the blood vessel much more precise.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
